Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 6, 1976 - Issue 1
56
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Implication of Rifampicin-quinone in the Irreversible Binding of Rifampicin to Macromolecules

&
Pages 21-32 | Received 22 Mar 1975, Published online: 30 Sep 2009
 

Abstract

1. When [3H]rifampicin is incubated with rat liver microsomes or rat liver homogenate, minor amounts are bound irreversibly to protein. This effect does not depend on the presence of NAD, NADH, NADP or NADPH.

2. Rifampicin is autoxidized at physiological pH. The product of autoxida-tion, rifampicin-quinone, if incubated with albumin, shows a much greater irreversible binding to the protein than the parent compound rifampicin. Hence it is concluded that rifampicin may bind irreversibly to proteins in a non-enzymic reaction after autoxidation to rifampicin-quinone.

3. Rifampicin-quinone also binds irreversibly to RNA and poly-L-lysine, if incubated with these compounds. This suggests that free amino groups of protein or RNA are involved in the binding.

4. 48 h after dosage of [3H]rifampicin (33 mg/kg) to rats, 29.2 ±4.1 (S.D.) pmol are bound irreversibly to 1 mg liver RNA, 15.8 ±8.1 pmol to 1 mg liver protein and 5.0 ± 0.47 pmol to 1 mg protein in brain tissue.

5. Microsomal NADPH-cytochrome c reductase is able to reduce rifampicin-quinone to rifampicin. The Km of this reaction is 10- 4 M. Induction of the NADPH-cytochrome c reductase by pre-treatment of rats with 20 mg/kg rifampicin over 5 days results in a corresponding increase of rifampicin-quinone reduction.

6. These results suggest that microsomal NADPH-cytochrome c reductase prevents accumulation of higher amounts of possibly toxic rifampicin-quinone by reduction to rifampicin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.